Immunocore Holdings Plc (IMCR)
35.36
-0.77
(-2.13%)
USD |
NASDAQ |
Sep 08, 16:00
35.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunocore Holdings Total Assets (Quarterly) : 1.119B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.119B |
| March 31, 2026 | 1.072B |
| December 31, 2025 | 1.067B |
| September 30, 2025 | 1.102B |
| June 30, 2025 | 1.082B |
| March 31, 2025 | 1.028B |
| December 31, 2024 | 1.010B |
| September 30, 2024 | 1.085B |
| June 30, 2024 | 1.023B |
| March 31, 2024 | 993.99M |
| December 31, 2023 | 597.00M |
| September 30, 2023 | 566.48M |
| June 30, 2023 | 559.85M |
| March 31, 2023 | 532.33M |
| Date | Value |
|---|---|
| December 31, 2022 | 523.88M |
| September 30, 2022 | 496.39M |
| June 30, 2022 | 358.95M |
| March 31, 2022 | 371.34M |
| December 31, 2021 | 408.74M |
| September 30, 2021 | 445.95M |
| June 30, 2021 | 487.67M |
| March 31, 2021 | 525.87M |
| December 31, 2020 | 269.55M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 245.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Silence Therapeutics Plc | 106.41M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 34.22M |
| Mereo BioPharma Group Plc | 34.71M |
| Compass Pathways Plc | 504.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 699.62M |
| Shareholders Equity (Quarterly) | 419.80M |
| Debt to Equity Ratio | 1.036 |
| Current Ratio | 4.469 |
| Net Debt Paydown Yield | -0.01% |